Filter posts

Health security threats are real: What is Congress doing?

In a rare show of bipartisan agreement, Congress recently passed and yesterday President Trump signed into …

BIO’s Hans Sauer Calls for Less Confusing Patent Eligibility Standards

Hans Sauer, BIO’s Deputy General Counsel for Intellectual Property, recently testified at the second of …

Licensing of Research Has Had Huge Impact on Economy & Jobs

A new report from BIO and AUTM demonstrates to enormous return on investment that ultimately …

Setting the Record Straight on March-In Rights

In a recent piece for The Washington Post, author Christopher Rowland inaccurately suggested that the federal government …

When Intervention Stifles Innovation

Dr. Gregory Dolin of the Center for Medicine and Law at the University of Baltimore …

Senator Roberts is a Champion of Biotechnology Innovation

Last night, U.S. Senator Pat Roberts (R-Kan.) accepted BIO’s Lifetime Achievement Award, which recognized his …

With an Air of Optimism, #BIOCEO19 Concludes

Despite considerable pressure directed squarely at biotech innovators from politicians of every stripe, biotech executives …

Happy 91st Birthday Senator Bayh!

At its best, government enables citizens to flourish socially and economically. Above and beyond the …

BIO Comments on Objectives for U.S. Japan Trade Agreement

BIO supports the U.S. Trade Representative’s (USTR) negotiations with the Government of Japan as an …

Drug Importation: Dangerous for Patients, Consumers, and American Communities

Writing for The Hill, Steve Forbes, Forbes Media Chairman and Editor in Chief, delivered a …